MarketCap
Facebook
X
TelegramGeschäftsbericht 2021
hinzugefügt 23.12.2023
Land |
 China |
IPO-Jahr |
2020 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBAL |
Anteile |
- |
Marktkapitalisierung |
$ 193 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Agilent Technologies
A
|
$ 117.5 | 2.1 % | $ 35.7 B | NYSE,SPB |  USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
CareDx, Inc
CDNA
|
$ 16.83 | 4.86 % | $ 897 M | Nasdaq Global Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Interpace Biosciences
IDXG
|
$ 2.2 | -4.35 % | $ 9.73 M | Nasdaq Global Select Market | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Co-Diagnostics
CODX
|
$ 1.45 | 5.84 % | $ 1.93 M | Nasdaq Capital Market | USA |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Castle Biosciences
CSTL
|
$ 23.53 | 1.73 % | $ 654 M | Nasdaq Global Market,SPB | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Charles River Laboratories International
CRL
|
$ 178.34 | 1.53 % | $ 8.84 B | NYSE,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Myriad Genetics
MYGN
|
$ 4.59 | 5.52 % | $ 425 M | Nasdaq Global Select Market,SPB | USA |
 |
Medpace Holdings
MEDP
|
$ 501.23 | 1.56 % | $ 14.5 B | Nasdaq Global Select Market,SPB | USA |
 |
NeoGenomics
NEO
|
$ 8.0 | 4.03 % | $ 1.02 B | Nasdaq Global Select Market,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 195.87 | 3.3 % | $ 140 B | NYSE,SPB | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Illumina
ILMN
|
$ 126.96 | 4.99 % | $ 20.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 15.3 | 6.03 % | $ 463 M | Nasdaq Global Market | USA |
 |
Senseonics Holdings
SENS
|
$ 6.72 | 0.6 % | $ 280 M | NYSE American | USA |
 |
Guardant Health
GH
|
$ 82.21 | 4.59 % | $ 10.3 B | Nasdaq Global Select Market,SPB | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
 |
Anixa Biosciences
ANIX
|
$ 2.85 | 5.95 % | $ 92.5 K | Nasdaq Capital Market | USA |
 |
Biomerica
BMRA
|
$ 2.08 | -2.8 % | $ 4.78 M | Nasdaq Capital Market | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 28.55 | 0.87 % | $ 20 B | NYSE | Niderland |
 |
ICON Public Limited Company
ICLR
|
$ 110.37 | 3.33 % | $ 9.1 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Soleno Therapeutics
SLNO
|
$ 52.64 | 0.02 % | $ 2.68 B | Nasdaq Capital Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 264.18 | 1.25 % | $ 22 B | NYSE,SPB | USA |
 |
Natera
NTRA
|
$ 201.9 | 4.6 % | $ 19.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Celcuity
CELC
|
$ 120.4 | 2.78 % | $ 5.63 B | Nasdaq Global Select Market | USA |
 |
Neuronetics
STIM
|
$ 1.39 | 2.96 % | $ 91.7 M | Nasdaq Global Select Market | USA |
 |
Lantheus Holdings
LNTH
|
$ 81.67 | 1.34 % | $ 5.51 B | Nasdaq Global Select Market,SPB | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Quest Diagnostics Incorporated
DGX
|
$ 192.91 | 0.73 % | $ 21.4 B | NYSE,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 9.14 | -2.97 % | $ 1.98 B | Nasdaq Global Select Market,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 5.19 | 5.06 % | $ 4.08 M | Nasdaq Global Select Market | USA |
 |
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | USA |
 |
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | USA |